Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiang Ge

Showing results (221-230 of 231) with videos related to

Pageof 24
Sort By:
Vaccine|January 27, 2009
Randomized-controlled phase II clinical trial of a bacterially expressed recombinant hepatitis E vaccineJun Zhang, Chong-Bo Liu, Rong-Cheng Li, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|June 26, 2018
Uncaria rhynchophylla Ameliorates Parkinson's Disease by Inhibiting HSP90 Expression: Insights from Quantitative ProteomicsYu-Long Lan, Jun-Jun Zhou, Jing Liu, et al.
Emerging Microbes & Infections|December 9, 2020
Specific determination of hepatitis B e antigen by antibodies targeting precore unique epitope facilitates clinical diagnosis and drug evaluation against hepatitis B virus infectionShao-Juan Wang, Zi-Min Chen, Min Wei, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 11, 2014
Biomarkers of rheumatoid arthritis-associated interstitial lung diseaseJuan Chen, Tracy J Doyle, Yongliang Liu, et al.
Journal of Medicinal Chemistry|April 2, 2026
Subamnex Ameliorates Hypoxia-Induced Pulmonary Arterial Hypertension through Modulation of the STAT3/p-STAT3 PathwayRui-Xiang Ge, Jun-Zhuo Shi, Bin-Hao Guo, et al.
Emerging Microbes & Infections|September 7, 2020
Robust neutralization assay based on SARS-CoV-2 S-protein-bearing vesicular stomatitis virus (VSV) pseudovirus and ACE2-overexpressing BHK21 cellsHua-Long Xiong, Yang-Tao Wu, Jia-Li Cao, et al.
The European Respiratory Journal|May 21, 2020
Serology characteristics of SARS-CoV-2 infection after exposure and post-symptom onsetBin Lou, Ting-Dong Li, Shu-Fa Zheng, et al.
Theranostics|January 2, 2015
Quantitative hepatitis B core antibody level is a new predictor for treatment response in HBeAg-positive chronic hepatitis B patients receiving peginterferonFeng-Qin Hou, Liu-Wei Song, Quan Yuan, et al.
Gut|March 31, 2019
A unique B cell epitope-based particulate vaccine shows effective suppression of hepatitis B surface antigen in miceTian-Ying Zhang, Xue-Ran Guo, Yang-Tao Wu, et al.
Cancers|April 3, 2021
Transitioning the Molecular Tumor Board from Proof of Concept to Clinical Routine: A German Single-Center AnalysisRouven Hoefflin, Adriana Lazarou, Maria Elena Hess, et al.
Pageof 24

Showing results (221-230 of 231) with videos related to

Sort By:
Pageof 24
Vaccine|January 27, 2009
Randomized-controlled phase II clinical trial of a bacterially expressed recombinant hepatitis E vaccineJun Zhang, Chong-Bo Liu, Rong-Cheng Li, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|June 26, 2018
Uncaria rhynchophylla Ameliorates Parkinson's Disease by Inhibiting HSP90 Expression: Insights from Quantitative ProteomicsYu-Long Lan, Jun-Jun Zhou, Jing Liu, et al.
Emerging Microbes & Infections|December 9, 2020
Specific determination of hepatitis B e antigen by antibodies targeting precore unique epitope facilitates clinical diagnosis and drug evaluation against hepatitis B virus infectionShao-Juan Wang, Zi-Min Chen, Min Wei, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 11, 2014
Biomarkers of rheumatoid arthritis-associated interstitial lung diseaseJuan Chen, Tracy J Doyle, Yongliang Liu, et al.
Journal of Medicinal Chemistry|April 2, 2026
Subamnex Ameliorates Hypoxia-Induced Pulmonary Arterial Hypertension through Modulation of the STAT3/p-STAT3 PathwayRui-Xiang Ge, Jun-Zhuo Shi, Bin-Hao Guo, et al.
Emerging Microbes & Infections|September 7, 2020
Robust neutralization assay based on SARS-CoV-2 S-protein-bearing vesicular stomatitis virus (VSV) pseudovirus and ACE2-overexpressing BHK21 cellsHua-Long Xiong, Yang-Tao Wu, Jia-Li Cao, et al.
The European Respiratory Journal|May 21, 2020
Serology characteristics of SARS-CoV-2 infection after exposure and post-symptom onsetBin Lou, Ting-Dong Li, Shu-Fa Zheng, et al.
Theranostics|January 2, 2015
Quantitative hepatitis B core antibody level is a new predictor for treatment response in HBeAg-positive chronic hepatitis B patients receiving peginterferonFeng-Qin Hou, Liu-Wei Song, Quan Yuan, et al.
Gut|March 31, 2019
A unique B cell epitope-based particulate vaccine shows effective suppression of hepatitis B surface antigen in miceTian-Ying Zhang, Xue-Ran Guo, Yang-Tao Wu, et al.
Cancers|April 3, 2021
Transitioning the Molecular Tumor Board from Proof of Concept to Clinical Routine: A German Single-Center AnalysisRouven Hoefflin, Adriana Lazarou, Maria Elena Hess, et al.
Pageof 24